search
Back to results

Heated Humidified Breathing Circuit Rewarming in Hypothermic Post Cardiopulmonary Bypass Patients.

Primary Purpose

Hypothermia, Rewarming

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Heated Humidified Breathing Circuit and Forced Air Blanket
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypothermia focused on measuring Cardiopulmonary bypass, Afterdrop, Deep Hypothermic Circulatory Arrest, Heated Humidified Breathing Circuit

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Admission to intensive care unit following surgical procedure involving cardiopulmonary bypass.
  • Admission temperature ≤ 35.0 C.

Exclusion Criteria:

  • Patients placed on extracorporeal membrane oxygenation intra-operatively, or during first 24 hours after ICU admission.
  • Any additional surgical procedures in the first 24 hours days after initial surgery e.g. Chest exploration for bleeding, Open Chest, Non-cardiac surgery such as colectomy for ischemic gut, etc.

Sites / Locations

  • Duke University Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

HHBC and Forced Air Warming

Arm Description

Patients admitted to intensive care unit hypothermic (≤ 35 C) following surgical procedures involving cardiopulmonary bypass. Will be rewarmed with heated humidified breathing circuits (ANAPOD) and standard forced air warming blankets.

Outcomes

Primary Outcome Measures

Time to Normothermia
Core temperature normothermia defined as >=36.5 C.

Secondary Outcome Measures

Time to Extubation
Time from admission to time of extubation. Followup was truncated at 24 hours and if patient had not been extubated at that time they were assigned a value of 24 hours.
Coagulopathy as Measured by Need for Transfusion of Blood Product
Assessed via number of transfusions of red blood cells, fresh frozen plasma, platelets, cryoprecipitate.
Metabolic Derangement as Measured by Time to Normal pH
Assessed via blood gas analysis. Normal pH defined as 7.35-7.45.
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Prothrombin Time
Laboratory assessment of Prothrombin Time with normal defined as 9.5-13.1 seconds.
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of INR
Laboratory assessment of international normalised ratio (INR) with normal defined as 0.9-1.1.
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Act Partial Thromboplastin Time
Laboratory assessment of Act Partial Thromboplastin Time with normal defined as 26.8-37.1 seconds.
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Fibrinogen.
Laboratory assessment of fibrinogen levels with normal defined as 213-435 mg/dL.
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Platelet Count
Laboratory assessment of platelet count with normal defined as 150 - 450 x10ˆ9/L.

Full Information

First Posted
September 27, 2018
Last Updated
July 2, 2020
Sponsor
Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT03697122
Brief Title
Heated Humidified Breathing Circuit Rewarming in Hypothermic Post Cardiopulmonary Bypass Patients.
Official Title
Heated Humidified Breathing Circuit Rewarming in Hypothermic Post Cardiopulmonary Bypass Patients.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
April 1, 2019 (Actual)
Primary Completion Date
June 15, 2019 (Actual)
Study Completion Date
June 15, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Hypothermia on admission to the intensive care unit (ICU) following cardiopulmonary bypass (CPB) is common. The investigators propose that rewarming hypothermic (≤ 35 C) patients admitted to the intensive care unit following procedures using CPB with heated humidified breathing circuits (HHBC) in addition to conventional forced air warming blankets will shorten time to normothermia. Secondarily it may shorten time to extubation, improve coagulopathy, and metabolic derangements seen with hypothermia.
Detailed Description
Hypothermia on admission to the intensive care unit (ICU) following cardiopulmonary bypass (CPB) is common. Cooling and rewarming during CPB and deep hypothermic circulatory arrest (DHCA) takes considerable time and contributes to the post-procedural coagulopathy and physiologic perturbations. Core body parts (trunk and head) rewarm more quickly than peripheral parts (extremities). After disconnecting from CPB the body is allowed to self equilibrate. The normal vasoconstriction response is impaired by the administered anaesthesia. Hence, heat distribution takes place from the warm core to the colder periphery. This causes an afterdrop: a decrease in the temperature of the core organs. After-drop may contribute to post-operative complications such as shivering, coagulopathy, increased myocardial stress, increased wound infections, metabolic acidosis, delayed extubation and prolonged ICU length of stay (LOS). The use of the active warming via traditional methods (ie forced air warming blankets) and Heated Humidified breathing circuits (HHBC) via ANAPOD Heated Humidification System® (ANAPOD) may shorten time to normothermia. Secondarily it may shorten time to extubation, improve coagulopathy, and metabolic derangements seen with hypothermia. Sample and Study Design- The investigators will prospectively collect data for 14 enrolled non-patients who will receive active warming via both forced air warming blankets and Heated Humidified breathing circuits (HHBC). Retrospective data will be obtained retrospectively for 28 matched patients from two years prior to initiation of the trial, who received warming only via forced air warming blankets. Data Collection Plan- Data will be extracted and collected by the Duke Department of Anesthesiology IT analyst, who will review and extract information from the patient's chart via Epic/ Maestro Care, or manually if necessary. Data Evaluation- Descriptive statistics will be used to evaluate patient demographics and clinical characteristics. Descriptive statistics will be summarized as mean ± (SD) or median (interquartile range) for continuous variables and group frequencies (%) for dichotomous or categorical variables. As all patients are expected to achieve normothermia within the study period, the primary outcome of time to normothermia will be analyzed as a numeric outcome variable. Following validation of distributional assumptions the investigators will compare the time to normothermia between the two groups via t-test or Wilcoxon rank sum test as appropriate. It is expected that the patients will reach normothermia between 45 minutes and 6 hours after admission to the ICU. By using a 2:1 matching ratio and a moderate level of variability (SD=1.3 hours) a study of 14 prospectively enrolled patients and 28 retrospectively matched patients would attain 82% power to detect a 1.25 hour difference between time to normothermia in the prospective group (active warming via traditional methods (ie forced air warming blankets) and Heated Humidified breathing circuits (HHBC) via ANAPOD Heated Humidification System® (ANAPOD), and the retrospective group (active warming via traditional methods (ie forced air warming blankets only) at alpha level 0.05. Secondary numeric outcomes such as time to extubation, time to normal PH, and coagulopathy lab values will be analyzed by t-test or Wilcoxon rank sum test as appropriate. Differences in categorical outcomes between treatment groups will be analyzed via chi-square or fisher exact tests. As the patients will be matched on key confounders no further adjustment is expected to be necessary, so the moderate sample size should not limit the primary analysis. Potential subgroup analysis may be conducted in an exploratory analysis to determine if the treatment effect of ANAPOD warming is different by procedure type or patient/surgical characteristics.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypothermia, Rewarming
Keywords
Cardiopulmonary bypass, Afterdrop, Deep Hypothermic Circulatory Arrest, Heated Humidified Breathing Circuit

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The intervention group has only one arm. All patients will use active warming via traditional methods (ie forced air warming blankets) and Heated Humidified breathing circuits (HHBC) via ANAPOD Heated Humidification System® (ANAPOD). Those patients will be matched with a retrospective historical cohort of patients that received active warming via traditional methods only (forced air warming blankets).
Masking
None (Open Label)
Allocation
N/A
Enrollment
14 (Actual)

8. Arms, Groups, and Interventions

Arm Title
HHBC and Forced Air Warming
Arm Type
Experimental
Arm Description
Patients admitted to intensive care unit hypothermic (≤ 35 C) following surgical procedures involving cardiopulmonary bypass. Will be rewarmed with heated humidified breathing circuits (ANAPOD) and standard forced air warming blankets.
Intervention Type
Device
Intervention Name(s)
Heated Humidified Breathing Circuit and Forced Air Blanket
Other Intervention Name(s)
ANAPOD
Intervention Description
Heated humidified breathing circuits (ANAPOD) will be set up and managed by respiratory therapist in standard fashion defined by the manufacturer. Temperate will be set at 41C. Forced air warming blankets will be set at 42C for duration of rewarming.
Primary Outcome Measure Information:
Title
Time to Normothermia
Description
Core temperature normothermia defined as >=36.5 C.
Time Frame
up to 24 hours post admission to intensive care unit
Secondary Outcome Measure Information:
Title
Time to Extubation
Description
Time from admission to time of extubation. Followup was truncated at 24 hours and if patient had not been extubated at that time they were assigned a value of 24 hours.
Time Frame
up to 24 hours post admission to intensive care unit
Title
Coagulopathy as Measured by Need for Transfusion of Blood Product
Description
Assessed via number of transfusions of red blood cells, fresh frozen plasma, platelets, cryoprecipitate.
Time Frame
24 hours post admission to intensive care unit
Title
Metabolic Derangement as Measured by Time to Normal pH
Description
Assessed via blood gas analysis. Normal pH defined as 7.35-7.45.
Time Frame
up to 24 hours post admission to intensive care unit
Title
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Prothrombin Time
Description
Laboratory assessment of Prothrombin Time with normal defined as 9.5-13.1 seconds.
Time Frame
24 hours post admission to intensive care unit
Title
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of INR
Description
Laboratory assessment of international normalised ratio (INR) with normal defined as 0.9-1.1.
Time Frame
24 hours post admission to intensive care unit
Title
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Act Partial Thromboplastin Time
Description
Laboratory assessment of Act Partial Thromboplastin Time with normal defined as 26.8-37.1 seconds.
Time Frame
24 hours post admission to intensive care unit
Title
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Fibrinogen.
Description
Laboratory assessment of fibrinogen levels with normal defined as 213-435 mg/dL.
Time Frame
24 hours post admission to intensive care unit
Title
Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Platelet Count
Description
Laboratory assessment of platelet count with normal defined as 150 - 450 x10ˆ9/L.
Time Frame
24 hours post admission to intensive care unit

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Admission to intensive care unit following surgical procedure involving cardiopulmonary bypass. Admission temperature ≤ 35.0 C. Exclusion Criteria: Patients placed on extracorporeal membrane oxygenation intra-operatively, or during first 24 hours after ICU admission. Any additional surgical procedures in the first 24 hours days after initial surgery e.g. Chest exploration for bleeding, Open Chest, Non-cardiac surgery such as colectomy for ischemic gut, etc.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Negmeldeen Mamoun, MD
Organizational Affiliation
Duke Univeristy Hospital Anesthesia Department
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Hospital
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Heated Humidified Breathing Circuit Rewarming in Hypothermic Post Cardiopulmonary Bypass Patients.

We'll reach out to this number within 24 hrs